Whitepaper
29 Sep 2024

TCC TB Tricalcium citrate as excipient for direct compression

PDF 305 kB

Direct compression has gained enormous popularity in tablet manufacturing in recent times. It is seen as the most economic process in terms of labour, time, equipment, operational energy, and space. What is more, direct compression also has the added advantage of eliminating problems due to heat and moisture that can occur during wet granulation. However, it places great demands on the excipients used in the process. Direct compression therefore requires that tablet formulations (active ingredients and excipients) exhibit good compactibility as well as flowability.

TCC TB is a tricalcium citrate tetrahydrate designed to function as a direct compression excipient. It combines exceptional compression characteristics, good flowability and good tolerability.

TCC TB is produced in a unique production process which creates the special crystalline structure that is responsible for its outstanding characteristics – making it ...

Content provided by our supplier

Jungbunzlauer

  • CH
  • 2022
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Excipients Manufacturer

Other Content from Jungbunzlauer (2)

  • News COMPREHENSIVE SOLUTIONS in Milan 2024

    We are looking forward to welcoming you at our booth no. 6A76 in hall 10.
    See you in Milan 2024!
    Your Jungbunzlauer Pharma Team

  • Brochure Active Pharmaceutical Ingredients and Excipients

    API
    Citric Acid AnhydrousTripotassium Citrate MonohydrateTrimagnesium Citrate AnhydrousTrisodium Citrate DihydrateExcipients 
     
    Citric AcidTrisodium CitrateGlucono-delta-LactoneSodium GluconateCalcium Lactate GluconateMonosodium CitratePotassium GluconateTricalcium CitrateTrimagnesium CitrateTripotassium CitrateZinc CitrateCITROFOL®️ AI and AII Citrate EstersFunctional Acids